Ameriprise’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.81M Sell
326,759
-29,052
-8% -$694K ﹤0.01% 2000
2025
Q1
$8.84M Buy
355,811
+31,550
+10% +$784K ﹤0.01% 1849
2024
Q4
$6.11M Buy
324,261
+194,597
+150% +$3.67M ﹤0.01% 2207
2024
Q3
$1.95M Sell
129,664
-58,293
-31% -$877K ﹤0.01% 2924
2024
Q2
$5.38M Sell
187,957
-18,055
-9% -$517K ﹤0.01% 2248
2024
Q1
$6.02M Sell
206,012
-8,617
-4% -$252K ﹤0.01% 2222
2023
Q4
$7.24M Sell
214,629
-11,515
-5% -$389K ﹤0.01% 2059
2023
Q3
$6.94M Sell
226,144
-19,958
-8% -$612K ﹤0.01% 2018
2023
Q2
$9.86M Sell
246,102
-12,864
-5% -$515K ﹤0.01% 1782
2023
Q1
$10.6M Buy
258,966
+1,957
+0.8% +$79.9K ﹤0.01% 1728
2022
Q4
$9.92M Sell
257,009
-52,227
-17% -$2.02M ﹤0.01% 1746
2022
Q3
$16.4M Sell
309,236
-2,308
-0.7% -$123K 0.01% 1302
2022
Q2
$18.2M Buy
311,544
+54,457
+21% +$3.17M 0.01% 1274
2022
Q1
$19.6M Buy
257,087
+432
+0.2% +$33K 0.01% 1363
2021
Q4
$15.4M Sell
256,655
-41,279
-14% -$2.48M ﹤0.01% 1611
2021
Q3
$16.7M Sell
297,934
-41,425
-12% -$2.32M 0.01% 1413
2021
Q2
$20.6M Sell
339,359
-4,849
-1% -$294K 0.01% 1330
2021
Q1
$24.1M Buy
344,208
+74,674
+28% +$5.23M 0.01% 1184
2020
Q4
$16.1M Buy
269,534
+29,899
+12% +$1.79M 0.01% 1390
2020
Q3
$14.4M Buy
239,635
+5,389
+2% +$324K 0.01% 1289
2020
Q2
$12.3M Buy
234,246
+18,907
+9% +$992K 0.01% 1376
2020
Q1
$7.22M Sell
215,339
-2,100
-1% -$70.4K ﹤0.01% 1638
2019
Q4
$9.85M Sell
217,439
-3,795
-2% -$172K ﹤0.01% 1753
2019
Q3
$8.42M Buy
+221,234
New +$8.42M ﹤0.01% 1839
2019
Q2
Sell
-92,040
Closed -$3.5M 3742
2019
Q1
$3.5M Sell
92,040
-817
-0.9% -$31.1K ﹤0.01% 2449
2018
Q4
$4M Buy
92,857
+44,181
+91% +$1.9M ﹤0.01% 2267
2018
Q3
$2.39M Sell
48,676
-1,929
-4% -$94.8K ﹤0.01% 2746
2018
Q2
$1.62M Sell
50,605
-118,263
-70% -$3.79M ﹤0.01% 2807
2018
Q1
$5.26M Sell
168,868
-120,716
-42% -$3.76M ﹤0.01% 2138
2017
Q4
$13.2M Sell
289,584
-694
-0.2% -$31.7K 0.01% 1387
2017
Q3
$10.9M Sell
290,278
-29,741
-9% -$1.12M 0.01% 1504
2017
Q2
$15.3M Buy
320,019
+37,488
+13% +$1.79M 0.01% 1225
2017
Q1
$12.9M Buy
282,531
+250,714
+788% +$11.4M 0.01% 1336
2016
Q4
$1.03M Sell
31,817
-121,305
-79% -$3.92M ﹤0.01% 2961
2016
Q3
$5.24M Sell
153,122
-85,624
-36% -$2.93M ﹤0.01% 1945
2016
Q2
$8.05M Buy
238,746
+40,183
+20% +$1.36M ﹤0.01% 1571
2016
Q1
$10.5M Buy
198,563
+127,174
+178% +$6.74M 0.01% 1373
2015
Q4
$5.49M Sell
71,389
-934,738
-93% -$71.8M ﹤0.01% 1947
2015
Q3
$41.3M Buy
1,006,127
+133,529
+15% +$5.49M 0.03% 564
2015
Q2
$61.7M Sell
872,598
-58,938
-6% -$4.17M 0.04% 446
2015
Q1
$82.8M Buy
931,536
+91,013
+11% +$8.09M 0.05% 367
2014
Q4
$74.5M Buy
840,523
+108,326
+15% +$9.6M 0.04% 397
2014
Q3
$71M Buy
732,197
+211,652
+41% +$20.5M 0.04% 415
2014
Q2
$47.8M Buy
520,545
+171,365
+49% +$15.7M 0.03% 554
2014
Q1
$24.4M Buy
349,180
+32,940
+10% +$2.31M 0.01% 871
2013
Q4
$18.2M Buy
316,240
+83,540
+36% +$4.8M 0.01% 1060
2013
Q3
$11.2M Buy
232,700
+195,527
+526% +$9.4M 0.01% 1385
2013
Q2
$1.08M Buy
+37,173
New +$1.08M ﹤0.01% 2582